Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biotech Stock Mailbag: Hep C Stock Winners
Biotech Stock Mailbag: Hep C Stock Winners
Biotech Stock Mailbag: Hep C Stock Winners
Submitted by
admin
on April 8, 2011 - 10:56am
Source:
TheStreet.com
News Tags:
hepatitis C
Pharmasset
Merck
Optimer
Vertex Pharmaceuticals
Gilead Sciences
JNJ
InterMune
Bristol-Myers Squibb
Headline:
Biotech Stock Mailbag: Hep C Stock Winners
Do Not Allow Advertisers to Use My Personal information
